These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 18829780

  • 21. Practitioner characteristics and the treatment of children and adolescents with attention deficit hyperactivity disorder.
    Mitchell PB, Levy F, Hadzi-Pavlovic D, Concannon PE, Hutchins P, Mulcahy DL, Clarke SD, Salmelainen PA, Warner A, Hughes CF.
    J Paediatr Child Health; 2012 Jun; 48(6):483-9. PubMed ID: 22111981
    [Abstract] [Full Text] [Related]

  • 22. Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder.
    Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Johnstone SJ.
    Clin Neurophysiol; 2007 Dec; 118(12):2700-8. PubMed ID: 17911040
    [Abstract] [Full Text] [Related]

  • 23. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O.
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [Abstract] [Full Text] [Related]

  • 24. Explaining racial and ethnic differences in children's use of stimulant medications.
    Hudson JL, Miller GE, Kirby JB.
    Med Care; 2007 Nov; 45(11):1068-75. PubMed ID: 18049347
    [Abstract] [Full Text] [Related]

  • 25. Diagnosing and treating attentional difficulties: a nationwide survey.
    McKenzie I, Wurr C.
    Arch Dis Child; 2004 Oct; 89(10):913-6. PubMed ID: 15383433
    [Abstract] [Full Text] [Related]

  • 26. Quantitative EEG analysis in dexamphetamine-responsive adults with attention-deficit/hyperactivity disorder.
    Bresnahan SM, Barry RJ, Clarke AR, Johnstone SJ.
    Psychiatry Res; 2006 Feb 28; 141(2):151-9. PubMed ID: 16343642
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL, American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee, American Heart Association Council on Cardiovascular Nursing.
    Circulation; 2008 May 06; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract] [Full Text] [Related]

  • 28. Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey.
    Chant C, Dos Santos CC, Saccucci P, Smith OM, Marshall JC, Friedrich JO.
    Crit Care Med; 2008 Apr 06; 36(4):1158-67. PubMed ID: 18379242
    [Abstract] [Full Text] [Related]

  • 29. Stimulant medications: a trade-off? The lived experience of adolescents with ADHD.
    Meaux JB, Hester C, Smith B, Shoptaw A.
    J Spec Pediatr Nurs; 2006 Oct 06; 11(4):214-26. PubMed ID: 16999743
    [Abstract] [Full Text] [Related]

  • 30. Attention deficit hyperactivity disorder medications in children with heart disease.
    Berger S.
    Curr Opin Pediatr; 2016 Oct 06; 28(5):607-12. PubMed ID: 27261563
    [Abstract] [Full Text] [Related]

  • 31. Patterns and knowledge of nonmedical use of stimulants among college students.
    Carroll BC, McLaughlin TJ, Blake DR.
    Arch Pediatr Adolesc Med; 2006 May 06; 160(5):481-5. PubMed ID: 16651489
    [Abstract] [Full Text] [Related]

  • 32. Injury among stimulant-treated youth with ADHD.
    Marcus SC, Wan GJ, Zhang HF, Olfson M.
    J Atten Disord; 2008 Jul 06; 12(1):64-9. PubMed ID: 17934179
    [Abstract] [Full Text] [Related]

  • 33. Trends in the prevalence of chronic medication use in children: 2002-2005.
    Cox ER, Halloran DR, Homan SM, Welliver S, Mager DE.
    Pediatrics; 2008 Nov 06; 122(5):e1053-61. PubMed ID: 18977954
    [Abstract] [Full Text] [Related]

  • 34. Management of a hyperactive teen and cardiac safety.
    Sowinski H, Karpawich PP.
    Pediatr Clin North Am; 2014 Feb 06; 61(1):81-90. PubMed ID: 24267459
    [Abstract] [Full Text] [Related]

  • 35. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Warshaw EM, Paller AS, Fowler JF, Zirwas MJ.
    Clin Ther; 2008 Feb 06; 30(2):326-37. PubMed ID: 18343271
    [Abstract] [Full Text] [Related]

  • 36. Illicit use of prescribed stimulant medication among college students.
    Hall KM, Irwin MM, Bowman KA, Frankenberger W, Jewett DC.
    J Am Coll Health; 2005 Feb 06; 53(4):167-74. PubMed ID: 15663065
    [Abstract] [Full Text] [Related]

  • 37. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
    Frindik JP, Morales A, Fowlkes J, Kemp S, Thrailkill K, Lippe B, Dana K.
    Horm Res; 2009 Feb 06; 72(3):160-6. PubMed ID: 19729947
    [Abstract] [Full Text] [Related]

  • 38. A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
    Papakostas GI, Petersen TJ, Perlis RH, Judy AE, Burns AM, Alpert JE, Birnbaum RJ, Fava M.
    J Clin Psychopharmacol; 2006 Apr 06; 26(2):216-8. PubMed ID: 16633159
    [No Abstract] [Full Text] [Related]

  • 39. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
    Waschbusch DA, Pelham WE, Waxmonsky J, Johnston C.
    J Dev Behav Pediatr; 2009 Apr 06; 30(2):158-68. PubMed ID: 19363369
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.